Research programme: milk derived peptides - Lactocore
Latest Information Update: 28 Mar 2026
At a glance
- Originator Lactocore
- Class Neuropsychotherapeutics; Osteoporosis therapies; Peptides
- Mechanism of Action CACNA2D1 protein modulators
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Osteoporosis
- No development reported Cognition disorders; Metabolic disorders; Psychiatric disorders
Most Recent Events
- 28 Mar 2026 No recent reports of development identified for preclinical development in Cognition-disorders in USA (Parenteral)
- 28 Mar 2026 No recent reports of development identified for preclinical development in Metabolic-disorders in USA (Parenteral)
- 28 Mar 2026 No recent reports of development identified for preclinical development in Psychiatric-disorders in USA (Intranasal)